Last reviewed · How we verify

NCT05895188

The Effect Of Virtual Reality Glasses Applied During Pap Smear On Anxiety, Pain And Patient Satisfaction

Status unknown NA Last updated 8 June 2023
What this trial tests

NA trial testing Virtual Reality Glasses in Anxiety in 60 participants. Status unknown.

Timeline
12 December 2022
Primary endpoint
17 October 2023
1 January 2024

Quick facts

Lead sponsorDuzce University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposesupportive care
Enrollment60
Start date12 December 2022
Primary completion17 October 2023
Estimated completion1 January 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Duzce University

Who can join

Adults 30 to 65, female only, with Anxiety or Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research is a randomized controlled experimental study designed to determine the effect of video, which is watched by virtual reality glasses during the procedure, on anxiety, pain and patient satisfaction to women who have had pap smear test.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Virtual Reality Glasses

Trials testing the same drug.

Other recruiting trials for Anxiety

Currently open trials in the same condition.

Other Duzce University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05895188.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing